Zacks: Brokerages Expect Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) to Post -$0.32 EPS
Brokerages forecast that Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) will report ($0.32) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Ekso Bionics Holdings’ earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.34). Ekso Bionics Holdings reported earnings per share of ($0.71) during the same quarter last year, which would indicate a positive year-over-year growth rate of 54.9%. The company is expected to issue its next quarterly earnings report after the market closes on Monday, August 7th.
According to Zacks, analysts expect that Ekso Bionics Holdings will report full-year earnings of ($1.06) per share for the current year, with EPS estimates ranging from ($1.42) to ($0.71). For the next year, analysts anticipate that the business will report earnings of ($0.91) per share, with EPS estimates ranging from ($1.50) to ($0.31). Zacks’ earnings per share averages are an average based on a survey of analysts that that provide coverage for Ekso Bionics Holdings.
Ekso Bionics Holdings (NASDAQ:EKSO) last posted its earnings results on Tuesday, May 9th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.03. The company had revenue of $1.44 million during the quarter, compared to analyst estimates of $2.38 million. Ekso Bionics Holdings had a negative return on equity of 788.27% and a negative net margin of 392.15%.
A number of equities analysts have recently issued reports on EKSO shares. Zacks Investment Research upgraded Ekso Bionics Holdings from a “sell” rating to a “hold” rating and set a $2.25 price objective for the company in a research report on Tuesday, May 9th. B. Riley restated a “buy” rating and set a $4.00 price objective on shares of Ekso Bionics Holdings in a research report on Wednesday, May 10th.
Ekso Bionics Holdings (EKSO) traded up 4.15% during trading on Monday, hitting $2.01. The stock had a trading volume of 181,105 shares. The company has a 50-day moving average of $1.99 and a 200 day moving average of $2.74. Ekso Bionics Holdings has a 52 week low of $0.99 and a 52 week high of $6.38. The company’s market cap is $51.52 million.
COPYRIGHT VIOLATION WARNING: This article was first reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/08/07/zacks-brokerages-expect-ekso-bionics-holdings-inc-nasdaqekso-to-post-0-32-eps.html.
A number of large investors have recently added to or reduced their stakes in EKSO. National Planning Corp boosted its stake in Ekso Bionics Holdings by 116.2% in the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after buying an additional 126,000 shares in the last quarter. Carl Domino Inc boosted its stake in Ekso Bionics Holdings by 74.7% in the second quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after buying an additional 35,088 shares in the last quarter. Finally, Independence Advisors LLC acquired a new stake in Ekso Bionics Holdings during the second quarter valued at approximately $1,840,000. 4.55% of the stock is owned by institutional investors and hedge funds.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.